Dec 08, 2024
SK Life Science, Inc. Presents XCOPRI® (cenobamate tablets) CV Data at the AES 2024 Annual Meeting Showing a Deeper Understanding of Cenobamate's Dual Mechanism of Action
Dec 02, 2024
Dr. Sunita Misra, MD, PhD, Selected as a Fellow of the American Epilepsy Society for Professional Accomplishment and Deep Commitment to the Field of Epilepsy
Nov 25, 2024
SK Life Science Presents Cenobamate Research at the 2024 American Epilepsy Society (AES) Annual Meeting
Apr 09, 2024
SK Life Science Announces Data Presentations for XCOPRI® (cenobamate tablets) CV at the 2024 American Academy of Neurology Annual Meeting
Mar 25, 2024
SK Life Science Celebrates Purple Day Highlighting Partnerships and Tools Designed to Empower People Living with Epilepsy in Their Journey to Achieve Zero Seizures
Mar 10, 2020
SK life science Receives Schedule V Designation from DEA for XCOPRI® (cenobamate tablets)
Dec 06, 2019
SK life science to Present Latest Cenobamate Data at the American Epilepsy Society 2019 Annual Meeting
Dec 02, 2019
SK Life Science, Inc. Announces FDA Acceptance of IND Application for Anti-Epileptic Drug Candidate SKL24741
Nov 13, 2019
Results of a Randomized Study of the Safety and Efficacy of Cenobamate in Adults with Uncontrolled Focal Seizures Published in The Lancet Neurology
Jul 17, 2019
SK life science Expands Support for the J. Kiffin Penry Epilepsy Education Programs to Reach More Healthcare Providers
May 03, 2019
SK life science to Showcase Scientific Data at the 2019 American Academy of Neurology Annual Meeting
Feb 04, 2019
SK life science announces FDA acceptance of NDA submission for cenobamate, an investigational antiepileptic drug
Dec 03, 2018
SK life science presents new data on its lead investigational compound, cenobamate, at the American Epilepsy Society 2018 Annual Meeting
May 15, 2018
SK life science Awards Educational Grant to J. Kiffin Penry Epilepsy Education Programs in Support of Neurology Residents and Epilepsy Fellows
Apr 23, 2018
SK life science presents data on the investigational antiepileptic drug, cenobamate, at the American Academy of Neurology Annual Meeting 2018
Mar 06, 2018
SK life science to present data on cenobamate, an investigational antiepileptic compound, at ASCPT 2018 Annual Meeting
Nov 29, 2017
SK life science launches new corporate presence, expanded commercial operations in the United States